» Authors » Mick Brammer

Mick Brammer

Explore the profile of Mick Brammer including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 31
Citations 1420
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Craig M, Sethna V, Gudbrandsen M, Pariante C, Seneviratne T, Stoencheva V, et al.
Psychol Med . 2022 Jul; 52(11):2017-2023. PMID: 35786785
Background: Offspring exposed to prenatal maternal depression (PMD) are vulnerable to depression across their lifespan. The underlying cause(s) for this elevated intergenerational risk is most likely complex. However, depression is...
2.
ONeill A, Wilson R, Blest-Hopley G, Annibale L, Colizzi M, Brammer M, et al.
Psychol Med . 2020 Jan; 51(4):596-606. PMID: 31994476
Background: Recent evidence suggests that cannabidiol (CBD), a non-intoxicating ingredient present in cannabis extract, has an antipsychotic effect in people with established psychosis. However, the effect of CBD on the...
3.
Turkheimer F, Hellyer P, Kehagia A, Expert P, Lord L, Vohryzek J, et al.
Neurosci Biobehav Rev . 2019 Jan; 99:3-10. PMID: 30684520
The concept of "emergence" has become commonplace in the modelling of complex systems, both natural and man-made; a functional property" emerges" from a system when it cannot be readily explained...
4.
Colizzi M, McGuire P, Giampietro V, Williams S, Brammer M, Bhattacharyya S
Exp Clin Psychopharmacol . 2018 Aug; 26(6):582-598. PMID: 30138003
Cannabis can induce transient psychotic and anxiety symptoms and long-lasting disorders. The acute psychoactive effects of its main active ingredient, (-)-trans-Δ9-tetrahydrocannabinol (Δ9-THC), may be modulated by previous cannabis exposure. Secondary...
5.
Colizzi M, McGuire P, Giampietro V, Williams S, Brammer M, Bhattacharyya S
Eur Neuropsychopharmacol . 2018 Jun; 28(7):850-862. PMID: 29935939
Cannabis use has been associated with psychosis and cognitive dysfunction. Some evidence suggests that the acute behavioral and neurocognitive effects of the main active ingredient in cannabis, (-)-trans-Δ9-tetrahydrocannabinol (∆9-THC), might...
6.
Bhattacharyya S, Falkenberg I, Martin-Santos R, Atakan Z, Crippa J, Giampietro V, et al.
Neuropsychopharmacology . 2014 Sep; 40(6):1343-52. PMID: 25249057
There is now considerable evidence to support the hypothesis that psychotic symptoms are the result of abnormal salience attribution, and that the attribution of salience is largely mediated through the...
7.
Christakou A, Gershman S, Niv Y, Simmons A, Brammer M, Rubia K
J Cogn Neurosci . 2013 Jul; 25(11):1807-23. PMID: 23859647
We examined the maturation of decision-making from early adolescence to mid-adulthood using fMRI of a variant of the Iowa gambling task. We have previously shown that performance in this task...
8.
Smith A, Cubillo A, Barrett N, Giampietro V, Simmons A, Brammer M, et al.
Biol Psychiatry . 2013 Jun; 74(8):615-22. PMID: 23731741
Background: The catecholamine agonists methylphenidate and atomoxetine effectively treat attention-deficit/hyperactivity disorder (ADHD). Furthermore, dopamine agonists have shown to improve time estimation in ADHD, a core cognitive deficit. However, few have...
9.
Coen S, Kano M, Farmer A, Kumari V, Giampietro V, Brammer M, et al.
Gastroenterology . 2011 Jun; 141(3):909-917.e1. PMID: 21699797
Background & Aims: One particularly important individual dynamic known to influence the experience of pain is neuroticism, of which little is known about in visceral pain research. Our aim was...
10.
Christakou A, Brammer M, Rubia K
Neuroimage . 2010 Sep; 54(2):1344-54. PMID: 20816974
Temporal discounting (TD) matures with age, alongside other markers of increased impulse control, and coherent, self-regulated behaviour. Discounting paradigms quantify the ability to refrain from preference of immediate rewards, in...